BioCentury
ARTICLE | Company News

Aradigm, GlaxoSmithKline deal

January 22, 2001 8:00 AM UTC

ARDM raised $5 million from GSK by exercising its put option under the companies' 1997 agreement to develop ARDM's AERx Pain Management System for pulmonary delivery of opiates and opioids in pain rel...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article